Clinical Trial: A Study to Evaluate the Efficacy and Safety of E2086 in Adults With Narcolepsy

U.S., March 26 -- ClinicalTrials.gov registry received information related to the study (NCT07493265) titled 'A Study to Evaluate the Efficacy and Safety of E2086 in Adults With Narcolepsy' on March 20.

Brief Summary: The primary purpose of this study is to evaluate the optimal doses of E2086 compared to placebo in participants with narcolepsy for reduction of excessive daytime sleepiness (EDS) as assessed by Mean Sleep Latency (MSL) (measured from the first 4 maintenance of wakefulness tests [MWTs]).

Study Start Date: March 23

Study Type: INTERVENTIONAL

Condition: Narcolepsy

Intervention: DRUG: E2086

E2086 oral tablets.

DRUG: Placebo

E2086 matching placebo tablet.

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Eisai Inc.

Publ...